Veramorph LLC
Norwood, MA Doing business as Veramorph
- UEI
- JZD1YYDDCLP5
- CAGE
- 7VP16
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 320 Norwood Park S #202, Norwood, MA 02062, USA
- Website
- veramorph.com
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Preclinical validation of an effective oral fulvestrant product as the future standard of care endocrine therapy for ER+… | National Cancer Institute | $399,985 | |
| Sbir phase II: design optimization and manufacturing scale-up of oral dosages with environmentally responsive polymers… | National Science Foundation | $1,199,999 | |
| Sbir phase i: hydrogel tablets as cost-effective oral dosages for solubility enhancement | Division of Industrial Innovation | $225,000 |
Quick answers
What is Veramorph LLC's UEI?
Veramorph LLC's Unique Entity ID (UEI) in SAM.gov is JZD1YYDDCLP5.
What is Veramorph LLC's CAGE code?
Veramorph LLC's CAGE code is 7VP16.
What is Veramorph LLC's primary NAICS code?
Veramorph LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Veramorph LLC located?
Veramorph LLC's physical address in SAM.gov is 320 Norwood Park S #202, Norwood, MA 02062, USA.
Is Veramorph LLC registered in SAM.gov?
Yes. Veramorph LLC's SAM.gov registration is active through August 19, 2027.
What is Veramorph LLC's most recent federal award?
Veramorph LLC's most recent federal grant award is Preclinical validation of an effective oral fulvestrant product as the future standard of care endocrine therapy for ER+… (R44CA306533), from National Cancer Institute, on September 10, 2025.
On GovTribe
See Veramorph LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors